1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Non-Invasive Aesthetic Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Non-Invasive Aesthetic Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Non-Invasive Aesthetic Treatment Market Regional Analysis
6.2 Europe Non-Invasive Aesthetic Treatment Market Revenue 2019-2028 (US$ Million)
6.3 Europe Non-Invasive Aesthetic Treatment Market Forecast Analysis
7. Europe Non-Invasive Aesthetic Treatment Market Analysis – by Procedure
7.1 Injectables
- 7.1.1 Overview
- 7.1.2 Injectables: Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Skin Rejuvenation
- 7.2.1 Overview
- 7.2.2 Skin Rejuvenation: Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Non-Invasive Aesthetic Treatment Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Clinics and Medical Spas
- 8.2.1 Overview
- 8.2.2 Clinics and Medical Spas: Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Non-Invasive Aesthetic Treatment Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Europe Non-Invasive Aesthetic Treatment Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 UK: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.1.2 UK: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Germany: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.2.2 Germany: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.3 France:
Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 France: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.3.2 France: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Russia: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.4.2 Russia: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.5.1 Italy: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.5.2 Italy: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Non-Invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by Procedure
- 9.2.1.6.2 Rest of Europe: Europe Non-Invasive Aesthetic Treatment Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Galderma
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Alma Lasers
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Merz Pharma
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bausch Health Companies Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Cutera Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 AbbVie Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Candela Medical
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Johnson and Johnson Services, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations